Growing community of inventors

Daejeon, South Korea

Ihl Young Choi

Average Co-Inventor Count = 8.00

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 4

Ihl Young ChoiJohan Neyts (2 patents)Ihl Young ChoiYoung Sik Jung (2 patents)Ihl Young ChoiHae Soo Kim (2 patents)Ihl Young ChoiSoo Bong Han (2 patents)Ihl Young ChoiHendrik Jan Thibaut (2 patents)Ihl Young ChoiChong Ock Lee (1 patent)Ihl Young ChoiHae Soo Kim (1 patent)Ihl Young ChoiPil Ho Kim (1 patent)Ihl Young ChoiChong Kgo Lee (1 patent)Ihl Young ChoiPhil Ho Kim (1 patent)Ihl Young ChoiJohan Neyts (1 patent)Ihl Young ChoiPil Ho Kim (1 patent)Ihl Young ChoiIhl Young Choi (2 patents)Johan NeytsJohan Neyts (25 patents)Young Sik JungYoung Sik Jung (9 patents)Hae Soo KimHae Soo Kim (9 patents)Soo Bong HanSoo Bong Han (8 patents)Hendrik Jan ThibautHendrik Jan Thibaut (7 patents)Chong Ock LeeChong Ock Lee (15 patents)Hae Soo KimHae Soo Kim (3 patents)Pil Ho KimPil Ho Kim (5 patents)Chong Kgo LeeChong Kgo Lee (2 patents)Phil Ho KimPhil Ho Kim (1 patent)Johan NeytsJohan Neyts (4 patents)Pil Ho KimPil Ho Kim (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Korea Research Institute of Chemical Technology (2 from 624 patents)

2. Katholieke Universiteit Leuven (1 from 346 patents)

3. Katholieke Universiteit Leuven, Ku Leuven R&d (1 from 238 patents)


2 patents:

1. 9833423 - 1,3-Di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient

2. 9346749 - 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/5/2026
Loading…